AI MARKET SCANNING

Immuneering Corporation

AVG HISTORICAL GAP +2.39%
MAX GAP RECORD +24.88%
🔒 PRO INSTITUTIONAL AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡

SENTINEL HISTORICAL GAP VIEWER

// $IMRX
📊 1-YEAR TIMELINE (GAPS PLOTTED) 🔮 SIMULATE SETUP 🔒
Bullish Opening Gap Bearish Opening Gap T-1 Close Baseline

CATALYSTS & GAP HISTORY

Aug 05, 2026 Earnings Release 2026-08-05 (AFTER CLOSE)
+5.69%
May 15, 2026 Earnings Release 2026-05-15 (BEFORE OPEN)
-0.78%
Mar 06, 2026 Earnings Release 2026-03-06 (UNDETERMINED)
+0.00%
Nov 12, 2025 Earnings Release 2025-11-12 (AFTER CLOSE)
+3.02%
Aug 13, 2025 Earnings Release 2025-08-13 (AFTER CLOSE)
-1.24%
May 06, 2025 Earnings Release 2025-05-06 (AFTER CLOSE)
+4.20%
Mar 21, 2025 Earnings Release 2025-03-21 (BEFORE OPEN)
-7.88%
Nov 13, 2024 Earnings Release 2024-11-13 (AFTER CLOSE)
+8.77%

VOLATILITY & GAP BIAS

AVG GAP MOVE 4.9%
Bullish Gaps (7)
Bearish Gaps (4)
Neutral / Flat (3)

QUANTITATIVE LIVE RADAR BLOTTER

Algorithmic execution stream for $IMRX

EXECUTIONS2 LOGS
STATUS🔒 ENCRYPTED
Execution Date Strategy & Setup Direction Execution Range Hold Time Net PnL
2026-10-30 🔒 PRO RADAR ••• x• $•••.•• → $•••.•• 0m +0.62%
••••-••-•• 🔒 LOCKED ••• x• $•••.•• → $•••.•• ••m +••.••%
🔒 Real-Time Strategy Telemetry Protected

Exact execution levels, Trailing Stops, and live bot signals are reserved for PRO members.

UNLOCK LIVE RADAR ⚡

📖 Intelligence Summary

Immuneering Corp. operates as a clinical-stage oncology company, which engages in developing medicines for cancer patients. Its pipeline of drug candidates focuses on treating aspects of disease that have eluded conventional approaches, including cancer cachexia and metastasis. The company was founded by Robert J. Carpenter and Benjamin J. Zeskind in…

NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗